No­var­tis cuts 275 jobs at Illi­nois site to con­sol­i­date Zol­gens­ma man­u­fac­tur­ing in North Car­oli­na

As No­var­tis con­tin­ues to re­shape it­self, the com­pa­ny is shut­ting the doors to one of its gene ther­a­py man­u­fac­tur­ing sites in the US.

The clo­sure of a site in Lib­er­tyville, IL, a city to the north­east of Chica­go, fol­lows a “com­pre­hen­sive man­u­fac­tur­ing site net­work eval­u­a­tion,” the com­pa­ny said in a state­ment to End­points News.

The de­ci­sion will cause 275 jobs to be axed, but the site is ex­pect­ed to re­main op­er­a­tional through the end of next year, with some ac­tiv­i­ties stop­ping ear­li­er as oth­ers will take time to com­plete. The com­pa­ny will of­fer 90-day no­ti­fi­ca­tions to work­ers along with sev­er­ance pack­ages, out­place­ment sup­port and oth­er ben­e­fits.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER